COMMUNIQUÉS West-GlobeNewswire

Nemaura Medical Interview to Air on Bloomberg International on the RedChip Money Report
14/06/2019
Loughborough, England, June 14, 2019 (GLOBE NEWSWIRE) -- – Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on the development of SugarBEAT® as a non-invasive, affordable and flexible [...]
Avadim Health Announces the Launch of its Second Consumer Clinical Innovation, Theraworx® Relief for Arthritic Joint Discomfort and Inflammation
14/06/2019
Theraworx® Relief, for Arthritic Joint Discomfort and Inflammation, Launching in 22,000 Pharmacy Locations Nationwide ASHEVILLE, N.C., June 14, 2019 (GLOBE NEWSWIRE) -- Avadim Health, Inc. (“Avadim”), the Bionome [...]
SELLAS Life Sciences Announces Pricing of $15 Million Public Offering
14/06/2019
NEW YORK, June 14, 2019 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) (“SELLAS” or the “Company”), a clinical stage biopharmaceutical company focused on the development of novel cancer [...]
Aura Signs Master Grower for Israel
14/06/2019
TORONTO, June 14, 2019 (GLOBE NEWSWIRE) -- Aura Health Inc. (the “ Company ” or “ Aura ”) ( CSE:BUZZ ) is pleased to announce the signing of master grower, Adrian Richelmi, to build and operate HolyCanna’s 60,000 square [...]
Krystal Submits Investigational New Drug (IND) Application for KB105, Topical Gene Therapy Candidate for Transglutaminase-1 Deficient Autosomal Recessive Congenital Ichthyosis
14/06/2019
KB105 is a new gene therapy candidate engineered with a Transglutaminase-1 (TGM1) gene construct to treat TGM1 deficient autosomal recessive congenital ichthyosis KB105 is the second pipeline product based on the STAR-D [...]
ORYZON Presents Preliminary Dose Finding Results of Phase II Trial With Iadademstat in AML
14/06/2019
Results presented at 24 th Congress of EHA in Amsterdam Combination of iadademstat and azacitidine shows good safety profile in elderly AML patients Recommended dose for Phase II established with only six patients Quick [...]
Bellwyck Pharma Services on Growth Path
14/06/2019
Expands Cold Storage Space in U.S., Adds Packaging Services in EU BURLINGTON, Ontario, June 14, 2019 (GLOBE NEWSWIRE) -- Bellwyck Pharma Services, a leader in primary and secondary packaging and labeling for the [...]
New Data Released by Theratechnologies Demonstrate Positive Impact of Tesamorelin in Patients With Liver Fibrosis
14/06/2019
NASH Development Strategy for tesamorelin to be Unveiled on June 17, 2019 MONTREAL, June 14, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce additional data from the [...]
De nouvelles données divulguées par Theratechnologies démontrent l’impact positif de la tésamoréline sur les patients présentant une fibrose du foie
14/06/2019
La stratégie de développement de la tésamoréline pour le NASH sera dévoilée le 17 juin 2019 MONTRÉAL, 14 juin 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer de [...]
G1 Therapeutics to Present Patient-Reported Outcomes (PRO) Data on Trilaciclib At Multinational Association of Supportive Care in Cancer (MASCC) And International Society of Oral Oncology (ISCOO) 2019 Annual Meeting
14/06/2019
RESEARCH TRIANGLE PARK, N.C., June 14, 2019 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that an analysis of patient-reported outcomes (PRO) data from [...]
Immunophotonics and Clinical Laserthermia Systems Announce Immuno-Oncology Research Collaboration and Clinical Trials for Cancer Patients with Solid Tumors
14/06/2019
Collaboration will Combine Immunophotonics’ Proprietary Drug, IP-001, and CLS’s TRANBERG Laser Thermal Therapy System and imILT Method ST. LOUIS and IRVINE, Calif., June 14, 2019 (GLOBE NEWSWIRE) -- Immunophotonics, Inc [...]
Immunophotonics and Clinical Laserthermia Systems Announce Immuno-Oncology Research Collaboration and Clinical Trials for Cancer Patients with Solid Tumors
14/06/2019
Collaboration will Combine Immunophotonics’ Proprietary Drug, IP-001, and CLS’s TRANBERG Laser Thermal Therapy System and imILT Method ST. LOUIS and LUND, Sweden, June 14, 2019 (GLOBE NEWSWIRE) -- Immunophotonics, Inc. [...]
Sorrento Therapeutics to Present at the JMP Securities Life Sciences Conference in New York (NY)
14/06/2019
SAN DIEGO, June 14, 2019 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento") announces today that senior management will be presenting in the upcoming JMP Life Sciences Conference in New York City [...]
Tauriga Sciences, Inc. Incorporates Private Limited Company in Belfast, Northern Ireland
14/06/2019
NEW YORK, NY, June 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG ) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, [...]
Aptose Presents New Preclinical Data for CG-806 at the 24th Congress of the European Hematology Association
14/06/2019
– CG-806 safely and durably suppressed tumor growth in preclinical models – SAN DIEGO and TORONTO, June 14, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a [...]
Kura Oncology Announces Positive Phase 2 Trial of Tipifarnib in Peripheral T-Cell Lymphoma
14/06/2019
– Primary endpoint achieved with 45% and 42% ORR in AITL and CXCL12+ AITL/PTCL-NOS expansion cohorts – – PTCL patients with tumors characterized by high CXCL12/CXCR4 expression ratio experienced an ORR of 47% and a [...]
Amphastar Pharmaceuticals to Present at the Raymond James Life Sciences and MedTech Healthcare Conference
14/06/2019
RANCHO CUCAMONGA, Calif., June 14, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, CFO, will be presenting at the Raymond James Life Sciences and MedTech [...]
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
14/06/2019
Company announcement – No. 22 / 2019 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, June 14, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 [...]
TLC Announces Part 1 Analysis of TLC590 Phase II Clinical Trial for Postsurgical Pain Management following Bunionectomy
14/06/2019
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, June 14, 2019 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of [...]

Pages